AETHLON MEDICAL INC AEMD
ASignal's systematic analysis rates AEMD as Bearish.
Reflects the latest available analysis · analyzed Sep 25, 2026
The case on AEMD
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong technical momentum with RSI above 80 and MACD above signal line
- Price trading well above 20-day and 50-day moving averages
- Low debt-to-equity ratio of 0.07x indicating strong balance sheet
- High current and quick ratios suggesting solid short-term liquidity
- Overbought RSI at 80.72, historically prone to pullbacks
- Negative forward P/E and EV/EBITDA suggesting unprofitable operations
- Zero gross, operating, and net margins indicating lack of profitability
- Negative return on equity and return on assets signaling capital inefficiency
- No Reddit mentions, indicating low retail investor interest or visibility
See the full verdict on AEMD
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes AEMD
Most investors never get a second opinion, let alone several. ASignal runs AEMD past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.